
Milestone Scientific MLSS
€ 0.28
-2.77%
Quartalsbericht 2026-Q1
hinzugefügt 13.05.2026
Land |
|
IPO-Jahr |
2015 |
Branche |
Medizinische Instrumente |
Börse |
NYSE AMERICAN |
Anteile |
82.1 M |
Marktkapitalisierung |
$ 27.1 M |
EBITDA (LTM) |
$ -5.37 M |
P/E (LTM) |
-5.83 |
P/S (LTM) |
3.16 |
EPS (LTM) |
-0.06 |
Andere Aktien der Branche "Medizinische Instrumente"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
The Cooper Companies
COO
|
$ 59.78 | -0.99 % | $ 11.9 B | NYSE,SPB | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
iRhythm Technologies
IRTC
|
$ 114.31 | 0.13 % | $ 3.66 B | Nasdaq Global Select Market,SPB | ||
|
ICU Medical
ICUI
|
$ 119.39 | -2.93 % | $ 2.94 B | Nasdaq Global Select Market,SPB | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Intuitive Surgical
ISRG
|
$ 421.75 | -1.47 % | $ 151 B | Nasdaq Global Select Market,SPB | ||
|
Repro Med Systems
KRMD
|
$ 3.93 | -1.26 % | $ 182 M | Nasdaq Capital Market | ||
|
Alcon
ALC
|
$ 63.78 | -0.34 % | $ 40.4 B | NYSE | ||
|
LeMaitre Vascular
LMAT
|
$ 97.38 | -2.13 % | $ 2.2 B | Nasdaq Global Market,SPB | ||
|
Masimo Corporation
MASI
|
$ 178.49 | 0.08 % | $ 9.51 B | Nasdaq Global Select Market,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | ||
|
Envista Holdings Corporation
NVST
|
$ 23.4 | -1.89 % | $ 3.93 B | NYSE | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
electroCore
ECOR
|
$ 6.04 | -6.07 % | $ 51.2 K | Nasdaq Global Select Market | ||
|
Haemonetics Corporation
HAE
|
$ 56.73 | -0.68 % | $ 2.86 B | NYSE,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
Glaukos Corporation
GKOS
|
$ 143.49 | 0.93 % | $ 6.95 B | NYSE,SPB | ||
|
STAAR Surgical Company
STAA
|
$ 32.41 | 1.25 % | $ 1.61 B | Nasdaq Global Market,SPB | ||
|
STERIS plc
STE
|
$ 211.83 | -1.92 % | $ 20.9 B | NYSE,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 130.52 | 0.18 % | $ 5.82 B | NYSE,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 8.65 | 0.46 % | $ 179 M | NYSE American | ||
|
Microbot Medical
MBOT
|
$ 1.88 | 1.35 % | $ 86.1 M | Nasdaq Global Select Market | ||
|
Merit Medical Systems
MMSI
|
$ 61.59 | -1.55 % | $ 3.64 B | Nasdaq Global Select Market,SPB | ||
|
Utah Medical Products
UTMD
|
$ 63.27 | -0.68 % | $ 205 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 303.95 | 1.25 % | $ 22 B | NYSE,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 24.33 | -10.22 % | $ 1.64 B | Nasdaq Global Select Market | ||
|
DENTSPLY SIRONA
XRAY
|
$ 9.99 | -3.99 % | $ 1.99 B | Nasdaq Global Select Market,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.65 | -5.8 % | $ 19.5 M | NYSE American | ||
|
Pro-Dex
PDEX
|
$ 59.75 | 1.88 % | $ 196 M | Nasdaq Global Select Market | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
BioLife Solutions
BLFS
|
$ 20.35 | -3.4 % | $ 972 M | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 1.89 | -3.08 % | $ 172 M | NYSE American | ||
|
Baxter International
BAX
|
$ 17.34 | -2.47 % | $ 8.9 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 202.44 | -0.01 % | $ 29.6 B | NYSE,SPB | ||
|
AtriCure
ATRC
|
$ 28.16 | 0.04 % | $ 1.34 B | Nasdaq Global Market,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 5.37 | -2.72 % | $ 238 M | Nasdaq Global Market | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
AngioDynamics
ANGO
|
$ 10.79 | -2.18 % | $ 441 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 143.35 | -0.77 % | $ 41.2 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 3.23 | -1.1 % | $ 34.3 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 3.07 | 3.9 % | $ 226 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 103.63 | 0.24 % | $ 5.83 M | Nasdaq Global Select Market,SPB |